secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2025-08-27T23:59:59+00:00
Accession:  0001641172-25-025693
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim receives Nasdaq deficiency notice for low stockholders' equity of $1.334M
-------------------------------------------------------------------------------

- Nasdaq notified Sonim on Aug 22, 2025 that stockholders' equity of $1.334M as of June 30, 2025 is below the $2.5M minimum for continued listing.
- Sonim also fails alternative compliance criteria (market value of listed securities $35M or net income $0.5M in recent fiscal years).
- Company has until Oct 6, 2025 to submit a compliance plan; if accepted, Nasdaq may grant up to 180 days to regain compliance.
- No immediate effect on trading of SONM common stock; Sonim is evaluating actions to regain compliance.
- No assurance that the plan will be accepted or that Sonim can regain compliance within the extension period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000164117225025693/0001641172-25-025693-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000164117225025693/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-025693

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer